Cell Pathways And Squibb Agree Joint Study

Cell Pathways, Inc. and Company plan to cooperate in supporting a clinical trial to study the combination of Aptosyn (exisulind) and TAXOL (paclitaxel) plus Paraplatin (carboplatin) as a first-line treatment for patients with advanced non- small cell lung cancer (NSCLC). This Phase I/II study is designed to evaluate escalating doses of Aptosyn in combination with a standard regimen of TAXOL plus Paraplatin.

The two companies intend to share the costs of this effort and share information.

“Our selective apoptotic anti-neoplastic drugs (SAANDs), including Aptosyn, have demonstrated synergistic anti-cancer effects in preclinical studies when combined with taxanes including TAXOL,” said Rifat Pamukcu, M.D., chief scientific officer of Cell Pathways.

“This new study extends the breadth of our current clinical investigations by using Aptosyn in combination with chemotherapeutic agents commonly used as first-line treatment in patients with NSCLC.

This is an indication where current treatment options are limited, and it is our hope that this drug combination may eventually demonstrate improvement in survival in this high mortality disease.”

Cell Pathways’ lead drug candidate, Aptosyn, is an investigational, oral agent that is designed to selectively trigger programmed cell death, or apoptosis, in precancerous and cancer cells via a mechanism of action different from currently marketed chemotherapeutic agents.

The combination of Bristol-Myers Squibb’s TAXOL and Paraplatin is the most commonly used regimen in community practice for the first-line treatment of NSCLC.

Cell Pathways, Inc., headquartered in Horsham, is a development stage pharmaceutical company focused on the research, development and commercialisation of novel and unique medications to prevent and treat cancer.

Get Dragon Pharma LLC

Tritren 150

Injectable Anabolic Steroid
Prime Ingredient: Trenbolones Blend
Made by: Dragon Pharma LLC
Amount: 1 X 10 ml (150 mg/ml)

Propionat 100 - Discount Price

Administration: Injection
Prime Component: Testosterone Propionate
Manufacturer: Dragon Pharmaceutical
Amount: 30 x 10 mL vial (100 mg/mL)
Price: 30 x $20.00

Dianabol 20 - Bulk Price

Administration: Oral
Main Constituent: Methandrostenolone
Manufacturer: Dragon Pharma LLC
Package: 10 x 100 tablets (20 mg/tablet)
Price: 10 x $39.00

Masteron 200 - Discount Price

Administration: Injection
Active Component: Drostanolone Enanthate
Produced by: Dragon Pharmaceuticals
Pack: 30 x 10 mL vial (200 mg/mL)
Price: 30 x $49.00

Enantat 250 - Discount Price

Administration: Injection
Principal Component: Testosterone Enanthate
Produced by: Dragon Pharmaceutical
Pack: 30 x 10 mL vial (250 mg/mL)
Price: 30 x $25.00

Clenbuterol - Cheap Price

Administration: Oral
Active Chemical Name: Clenbuterol Hydrochloride
Producer: Dragon Pharmaceuticals
Unit: 20 x 100 tabs (40 mcg/pastille)
Price: 20 x $25

1-Test Cyp 200

Injectable Anabolic Steroid
Base Chemical Name: Dihydroboldenone Cypionate
Produced by: Dragon Pharmaceutical
Pack: 1 X 10 mL vial (200 mg/mL)

Cypionat 250

Injectable Steroid for Muscle Growth
Basal Chemical Name: Testosterone Cypionate
Manufacturer: Dragon Pharmaceuticals
10 mL Sterile Multi-dose Vial (250 mg/mL)

Winstrol 50

Injectable Steroid for Muscle Growth
Basal Component: Stanozolol
Manufacturer: Dragon Pharma Labs
10 mL Sterile Multi-dose Vial (50 mg/mL)

EQ 300

Injectable Steroid for Muscle Growth
Basal Ingredient: Boldenone Undecylenate
Produced by: Dragon Pharmaceuticals
10 mL Sterile Multi-dose Vial (300 mg/mL)

Masteron 200

Prime Component: Drostanolone Enanthate
Made by: Dragon Pharma Labs
Unit: 10 x 10 mL vial (200 mg/mL)

Cut Long 300

Prime Constituent: Drostanolone Enanthate, Testosterone Enanthate
Trenbolone Enanthate
Branded by: Dragon Pharmaceutical
Pack: 10 mL vial (300 mg/mL)